Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
S&P affirms Jordan's 'BB-/B' rating; outlook stable.
2026-08-29
S&P affirms Jordan's 'BB-/B' rating; outlook stable.
Back
Other News
2026-08-28
U.S. pharmaceutical stocks declined, with BioNTech (BNTX.O) falling 11%, its biggest intraday drop since March 10, after the company announced the termination of its Phase 2 clinical trial for colorectal cancer. Moderna (MRNA.O) fell 5%, and Merck (M
U.S. pharmaceutical stocks declined, with BioNTech (BNTX.O) falling 11%, its biggest intraday drop since March 10, after the company announced the termination of its Phase 2 clinical trial for colorectal cancer. Moderna (MRNA.O) fell 5%, and Merck (MRK.N) fell 1.3%.
2026-08-28
Meituan (03690.HK) reported adjusted net profit of RMB 2.52 billion in the second quarter, a year-on-year increase of 69%.
Meituan (03690.HK) reported adjusted net profit of RMB 2.52 billion in the second quarter, a year-on-year increase of 69%.
Chat with us
, powered by
LiveChat